Free Trial

Guardian Pharmacy Services (NYSE:GRDN) Shares Down 5.3% - What's Next?

Guardian Pharmacy Services logo with Medical background
Remove Ads

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) shares fell 5.3% during mid-day trading on Friday . The company traded as low as $19.50 and last traded at $20.48. 46,141 shares were traded during mid-day trading, a decline of 70% from the average session volume of 153,686 shares. The stock had previously closed at $21.63.

Guardian Pharmacy Services Price Performance

The business has a 50-day moving average of $20.56.

Hedge Funds Weigh In On Guardian Pharmacy Services

Institutional investors and hedge funds have recently bought and sold shares of the business. R Squared Ltd purchased a new stake in shares of Guardian Pharmacy Services during the fourth quarter worth $30,000. Investment Research & Advisory Group Inc. purchased a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth about $34,000. BNP Paribas Financial Markets acquired a new stake in shares of Guardian Pharmacy Services during the 4th quarter valued at about $37,000. Compass Financial Services Inc bought a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at approximately $58,000. Finally, JPMorgan Chase & Co. bought a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at approximately $77,000.

Guardian Pharmacy Services Company Profile

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Featured Articles

Should You Invest $1,000 in Guardian Pharmacy Services Right Now?

Before you consider Guardian Pharmacy Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.

While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads